SCHEMBL1261863

SCHEMBL1261863

C[Si](C)(C)O[Si](C)(CCC1CCC2OC2C1)CCC1CCC2OC2C1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.32
PTGS2 P35354 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5162214 0.86 PTGS1 (0.34) PTGS1PTGS2
SCHEMBL30831373 0.86 PTGS1 (0.32) PTGS1PTGS2
SCHEMBL11075346 0.86 PTGS1 (0.32) PTGS1PTGS2
SCHEMBL2846573 0.86 PTGS1 (0.32) PTGS1PTGS2
SCHEMBL15941576 0.86 PTGS1 (0.32) PTGS1PTGS2
SCHEMBL19622363 0.82 PTGS1 (0.36) PTGS1PTGS2
SCHEMBL1079186 0.82 PTGS1 (0.36) PTGS1PTGS2
SCHEMBL1439702 0.82 PTGS1 (0.33) PTGS1PTGS2
SCHEMBL1101898 0.81 PTGS1 (0.30) PTGS1PTGS2
SCHEMBL26664382 0.81 PTGS1 (0.32) PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113789143-B Room-temperature curable organic silicon modified epoxy resin pouring sealant and preparation method thereof 东莞市雄驰电子有限公司 2022-12-27 CN claimed
CN-113881377-B Anhydride-curable organic silicon modified epoxy resin pouring sealant and preparation method thereof 东莞市雄驰电子有限公司 2022-12-20 CN claimed
EP-4045573-A1 METHOD FOR THE PRODUCTION OF A CONTINUOUS ELASTOMERIC FILM Synthomer Sdn. Bhd. (MY) 2022-08-24 EP claimed
CN-114555680-A Method for producing elastomeric films 昕特玛私人有限公司 2022-05-27 CN claimed
US-8808732-B2 Film forming personal care compositions and methods SHAOSHENG DONG (US) 2014-08-19 US claimed
US-20130203882-A1 Curable Composition HUNTSMAN INTERNATIONAL LLC (US) 2013-08-08 US claimed
US-20130058880-A1 FILM FORMING PERSONAL CARE COMPOSITIONS AND METHODS DONG SHAOSHENG (US) 2013-03-07 US claimed
WO-2011143131-A1 FILM FORMING PERSONAL CARE COMPOSITIONS AND METHODS DONG SHAOSHENG (US) 2011-11-17 WO claimed
US-12365773-B2 Method for the production of a continuous elastomeric film SYNTHOMER SDN. BHD. (MY) 2025-07-22 US disclosed
WO-2024176886-A1 CURABLE RESIN COMPOSITION AND ADHESIVE FOR LED ELEMENT 積水化学工業株式会社 2024-08-29 WO disclosed
CN-116041709-B Preparation method and application of photo-curing phenyl fluorosilicone modified epoxy paint and coating 安徽立兴新材料有限公司 2024-07-16 CN disclosed
US-20240174889-A1 ULTRAVIOLET-CURABLE COMPOSITION AND USE THEREOF DOW TORAY CO LTD (JP) 2024-05-30 US disclosed
US-20240141117-A1 METHOD FOR THE PRODUCTION OF A CONTINUOUS ELASTOMERIC FILM SYNTHOMER SDN. BHD. (MY) 2024-05-02 US disclosed
WO-2023126918-A1 UV-CURABLE INKJET INKS KORNIT DIGITAL LTD. (IL) 2023-07-06 WO disclosed
US-20050008865-A1 Curable epoxy compositions and articles made therefrom GENERAL ELECTRIC COMPANY 2005-01-13 US disclosed
US-20040138343-A1 Functionalized colloidal silica, dispersions and methods made thereby CAMPBELL JOHN ROBERT (US) 2004-07-15 US disclosed
WO-2004048266-A1 FUNCTIONALIZED COLLOIDAL SILICA, DISPERSIONS AND METHODS MADE THEREBY GENERAL ELECTRIC COMPANY (US) 2004-06-10 WO disclosed
WO-2004048457-A1 CURABLE EPOXY COMPOSITIONS, METHODS AND ARTICLES MADE THEREFROM GENERAL ELECTRIC COMPANY (A NEW YORK CORPORATION) (US) 2004-06-10 WO disclosed
US-20040102529-A1 Functionalized colloidal silica, dispersions and methods made thereby GENERAL ELECTRIC COMPANY 2004-05-27 US disclosed
US-20040101688-A1 Curable epoxy compositions, methods and articles made therefrom GENERAL ELECTRIC COMPANY 2004-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130058880-A1 FILM FORMING PERSONAL CARE COMPOSITIONS AND METHODS CUTA, PWWP2B, WIZ PTGS1 1496/4885PTGS2 2114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.